InvestorsHub Logo
Followers 17
Posts 752
Boards Moderated 0
Alias Born 10/20/2013

Re: sante1 post# 238

Wednesday, 05/18/2016 11:36:53 AM

Wednesday, May 18, 2016 11:36:53 AM

Post# of 733
Yes, nice price action after the IQWIG report. But as you say, we are still very much undervalued.

NASDAQ: I don't think Dr. Wolgen will take us to Nasdaq any day soon.
There is an added value of being on the ASX in a time where
we would be easy prey for shorters and other manipulators. This is not happening to the same extent on the ASX. I am also involved in other pharma companies here in the US and especially one of them, CT$X is getting killed by all sorts of manipulation. It's sad to watch. Clinuvel's succes is reliant on steady growth, trustworthy management and time. Right now we have it all but going to Nasdaq before the company has some fat on its bones would not be beneficial IMO. Also, I personally believe that stocks are in for a dramatic decline. When that happens, it will be good to be a small unknown, undervalued company sheltered on the ASX.

Give it time my friend. In a volatile World with crazy P/E ratios and bloated stock prices it's good to be one of the few companies that actually executes quietly.